Interinstitutional variations in planning for stereotactic body radiation therapy for lung cancer.
about
Design, development of water tank-type lung phantom and dosimetric verification in institutions participating in a phase I study of stereotactic body radiation therapy in patients with T2N0M0 non-small cell lung cancer: Japan Clinical Oncology GroupAdvances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy.Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapyDosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer.Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors.Approach to dose definition to the gross tumor volume for lung cancer with respiratory tumor motion.Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma - benchmark for a prospective multi-institutional study.Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC).JCOG Radiation Therapy Study Group: history and achievements.Clinical introduction of Monte Carlo treatment planning for lung stereotactic body radiotherapy.Radiation pneumonitis after stereotactic radiation therapy for lung cancer.Impact of dose calculation algorithm on radiation therapy.Stereotactic radiotherapy of intrapulmonary lesions: comparison of different dose calculation algorithms for Oncentra MasterPlan®Stereotactic body radiotherapy for small lung tumors in the University of Tokyo Hospital.Dosimetric evaluation of the impacts of different heterogeneity correction algorithms on target doses in stereotactic body radiation therapy for lung tumors.Experimental evaluations of the accuracy of 3D and 4D planning in robotic tracking stereotactic body radiotherapy for lung cancers.Effects of collimator angle, couch angle, and starting phase on motion-tracking dynamic conformal arc therapy (4D DCAT).Detailed evaluation of an automated approach to interactive optimization for volumetric modulated arc therapy plans.Evaluation of 4D dose to a moving target with Monte Carlo dose calculation in stereotactic body radiotherapy for lung cancer.Geometrical differences in target volumes between slow CT and 4D CT imaging in stereotactic body radiotherapy for lung tumors in the upper and middle lobe.
P2860
Q33582628-F94240A9-5456-47FC-BE8B-B427054C8D74Q33645619-D0D96104-89A3-4F19-95DF-9461D862E9E6Q33875793-2B8FD0BD-E3A0-4338-9138-53956C7E69CAQ34024586-68D8DC11-C284-4972-8047-71D06863E588Q35846913-29853ED4-3699-49C8-BB63-A52572733102Q36499983-8C3A0E20-DBDB-4D7D-A4AE-31A190418A1DQ36843349-65374AD8-5DFC-43E7-ABA8-49E27F7C7625Q37491637-79179DF9-7FA4-4FF2-8C9F-710C8B072767Q37943284-D5B0628B-A619-4A60-A7EF-21A65034B99DQ38178429-9E7C70E2-888F-42C7-AB36-4B850D09D44CQ38256158-032DA902-864A-49BD-8F0C-8B252C0B5CF9Q38272276-2A79469A-F633-4C00-B3B0-DEA8AB4D11A2Q39320180-C30DBE0B-D641-40E2-B9B8-C34BC3CECDA1Q42033188-0279126A-765C-497D-BDE8-5F06007CD2C5Q42321832-FCD52DF3-714D-423D-B8CE-D150F28CBB35Q44551378-C24E4A7A-49AD-4E03-BCFD-EAF8C8CBFCE8Q47826009-B13046E2-4511-491B-AC2E-0B1F3D2D1EABQ50864932-54FB990C-A262-4E3C-BF1A-1A7B17F29381Q51286974-2A153C06-DAC3-4994-BA54-D478243C4F15Q53391674-16E3EF0B-F101-49B1-A663-01312C0C7052
P2860
Interinstitutional variations in planning for stereotactic body radiation therapy for lung cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Interinstitutional variations ...... ation therapy for lung cancer.
@en
Interinstitutional variations ...... ation therapy for lung cancer.
@nl
type
label
Interinstitutional variations ...... ation therapy for lung cancer.
@en
Interinstitutional variations ...... ation therapy for lung cancer.
@nl
prefLabel
Interinstitutional variations ...... ation therapy for lung cancer.
@en
Interinstitutional variations ...... ation therapy for lung cancer.
@nl
P2093
P1476
Interinstitutional variations ...... ation therapy for lung cancer.
@en
P2093
Etsuo Kunieda
Kenji Takayama
Kunihiko Tateoka
Masahiro Hiraoka
Masato Sakamoto
Naoki Ishizuka
Satoshi Ishikura
Takashi Mizowaki
Yasushi Nagata
Yoshiki Norihisa
P304
P356
10.1016/J.IJROBP.2006.12.012
P407
P577
2007-03-23T00:00:00Z